Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.51 |
| ▸ | RELA | Q04206 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | ACR | P10323 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25867852 | 0.90 | LMNA (0.60) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL9340086 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL302534 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL14126016 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL302606 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL10526346 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL11869629 | 0.88 | LMNA (0.67) | KMT2ALMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL302512 | 0.87 | ALDH1A1 (0.57) | KMT2ALMNASMN1; SMN2CYP2D6MAPT | |
| SCHEMBL27828947 | 0.87 | ALDH1A1 (0.57) | KMT2ALMNASMN1; SMN2CYP2D6MAPT | |
| SCHEMBL20211763 | 0.87 | ALDH1A1 (0.57) | KMT2ALMNASMN1; SMN2CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092712-B2 | Bent-core LC decorated gold nanoclusters | Ridout & Maybee LLP (CA) | 2012-01-10 | — | — | US | disclosed |
| US-20110062385-A1 | BENT-CORE LC DECORATED GOLD NANOCLUSTERS | UNIVERSITY OF MANITOBA (CA) | 2011-03-17 | — | — | US | disclosed |
| WO-2009052632-A1 | BENT-CORE LC DECORATED GOLD NANOCLUSTERS | UNIVERSITY OF MANITOBA (CA) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110062385-A1 | BENT-CORE LC DECORATED GOLD NANOCLUSTERS | SLC6A13, SLC6A6, LGALS3 | KMT2A 2885/4885LMNA 1010/4885NPC1 972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.